论文部分内容阅读
目的探讨酚妥拉明联合血凝酶针治疗大咯血的临床疗效。方法将62例大咯血病人随机分为两组,治疗组:酚妥拉明联合血凝酶针组32例,对照组:采用垂体后叶素治疗组30例,其余治疗两组同。结果治疗组总有效率为93.75%,对照组总有效率70%,两组显效率比较具有统计学差异(P<0.05)。治疗组血压升高和胃肠道反应副作用发生率显著低于对照组。结论酚妥拉明联合血凝酶治疗大咯血效果明显优于垂体后叶素,且不良反应小。
Objective To investigate the clinical efficacy of phentolamine combined with hemagglutinin acupuncture in treating hemoptysis. Methods 62 patients with massive hemoptysis were randomly divided into two groups. The treatment group consisted of 32 cases of phentolamine combined with hemagglutinin acupuncture. The control group: 30 cases treated with pituitrin and the other two groups treated with the same treatment. Results The total effective rate was 93.75% in the treatment group and 70% in the control group, with significant difference between the two groups (P <0.05). The incidence of hypertension and gastrointestinal side effects in the treatment group was significantly lower than that in the control group. Conclusion Phentolamine combined with hemagglutinin treatment of hemoptysis was significantly better than pituitrin, and adverse reactions.